ELAREM™ Perform
Pre-clinical & Therapeutic Cell Expansion
Key Facts
About PL BioScience
PL BioScience is an emerging biotech firm focused on revolutionizing cell culture through its proprietary Human Platelet Lysate (HPL) platform, ELAREM™. The company offers a broad portfolio of HPL products designed to replace fetal bovine serum (FBS) in research, diagnostics, and therapeutic cell manufacturing, addressing the growing demand for animal-free, clinically relevant supplements. Its technology supports 2D and 3D cell culture across various safety grades (Research, GMP, GMP-Clinical), positioning it at the intersection of regenerative medicine and advanced in vitro models. PL BioScience aims to bridge the gap between academic research and clinical applications with high-performance, affordable solutions.
View full company profile